Furkan Sendogan

Dr. Furkan Sendogan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
TTTurgay Turan
Turgay Turan
BGBerrin Güçlüer
Berrin Güçlüer
ÖEÖzgür Efiloğlu
Özgür Efiloğlu
FSFurkan Sendogan
Furkan Sendogan
RARamazan Gökhan Atış
Ramazan Gökhan Atış
AYAsıf Yıldırım
Asıf Yıldırım
Objective: To investigate the factors to predict Gleason score upgrading (GSU) of patients with prostate cancer who were evaluated by using the International Society for Urological Pathology (ISUP) 2014 Gleason grading system. Material and methods: Between January 2008 and December 2015, we retrospectively investigated patients who had undergone radical prostatectomy and followed up in the uro-oncology outpatient clinic. The pathologic specimens of the patients were evaluated based on the ISUP 2014 classification system. The patients were divided into two groups with or without upgraded Gleason scores. Factors that could be effective in predicting upgrading such as age, prostate-specific antigen (PSA), prostate volume, D’Amico risk classification, PSA density, cancer of the prostate risk assessment (CAPRA) scores, biopsy tumor percentage, body mass index, and clinical stage parameters were compared between both groups. Results: Of the 265 patients who could be evaluated and followed up regularly, Gleason score upgrades were observed in 110 (41.5%) patients. Advanced age (p=0.009), PSA >20 ng/mL (p=0.036), PSA density >0.35 (p=0.005), high CAPRA score (p=0.031), and high biopsy tumor percentage (p=0.009) were discovered to be correlated with Gleason score upgrade in univariate logistic regression analysis. Advanced age alone was a predictor for GSU in multivariate logistic regression analysis (p=0.002). Five-year biochemical recurrence-free survival rate was 86% in the non-GSU group and 55% in the GSU group (p<0.001). Conclusion: GSU risk should be taken into consideration in making therapeutic decisions for older patients with prostate cancer, and precautions should be taken against development of aggressive disease. Cite this article as: Turan T, Güçlüer B, Efiloğlu Ö, Şendoğan F, Atış RG, Çaşkurlu T, et al. The factors predicting upgrading of prostate cancer by using International Society for Urological Pathology (ISUP) 2014 Gleason grading system. Turk J Urol 2019; 45(Supp. 1): S36-S41.

1 January 2023 in Urology Research and Practice
Verified
Journal Article
Open access
FSFurkan Sendogan
Furkan Sendogan
TTTurgay Turan
Turgay Turan
HEHayriye Erman
Hayriye Erman
YDYavuz Onur Danacioglu
Yavuz Onur Danacioglu
FIFerruh Kemal Isman
Ferruh Kemal Isman
AYAsif Yildirim
Asif Yildirim
Objective: The immune system has an essential role in the development of cancer by showing both anti-tumor and pro-tumor activities. Understanding the immune func- tion of patients with malignancy is of clinical importance for the evaluation, treatment, and prognosis of the disease. We aimed to evaluate lymphocyte subtypes in peripheral blood samples of prostate cancer patients and their relationship with clinicopathologi- cal features and prognosis. Methods: One hundred thirty-seven patients who underwent open radical prosta- tectomy were included in our study. The percentages of CD3+T lymphocyte, CD19+ B lymphocyte, CD16/56 natural killer cells, CD4+ helper T lymphocyte, CD8+ cytotoxic T lymphocyte, and CD45 total lymphocyte were evaluated for each patient using the blood sample taken into a hemogram tube before surgery. Results: The pathological stage was T2 for 64 of the cases and T3 for 73. The mean follow-up period of the patients was 12.81 ± 6.20 months. The CD3+/CD4+ counts of the patients with pathological stage T2 were found to be statistically significantly higher than stage T3. There was a statistically significant negative correlation between the prostate-specific antigen levels and CD3+/CD4+ percentages of the patients. There was no statistical significance between the percentages of lymphocyte subtypes and the presence of surgical margin, biochemical recurrence, adjuvant therapy, and cancer upgrade. Conclusion: We consider that the increase in the pathological stage and prostate-spe- cific antigen value and the decrease in the number of CD4+ T lymphocyte subtypes may be prognostic markers in prostate cancer patients. Cite this article as: Sendogan F, Turan T, Erman H, et al. The relationship between lymphocyte subtypes with clinicopathological features and prognosis of prostate cancer in patients undergoing radical prostatectomy. Urol Res Pract. 2023;49(4):253-258.

15 February 2021 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
MÇMehmet Çağlar Çakici
Mehmet Çağlar Çakici
AIAyberk İpLi̇kÇi̇
Ayberk İpLi̇kÇi̇
FSFurkan Sendogan
Furkan Sendogan
TTTurgay Turan
Turgay Turan
ÖEÖzgür Efi̇lOğlu
Özgür Efi̇lOğlu
AYAsıf YILDIRIM
Asıf YILDIRIM
Amaç: Her ne kadar etkili ve güvenli bir kullanım alanı olsa da double-J stent (DJS) kullanımı ile ilgili farklı komplikasyonlar ortaya çıkabilmektedir. Bu çalışmada böbrek taşı nedeniyle retrograd intrarenal cerrahi (RIRC) yapılan hastalarda DJS migrasyonunun klinik sonuçlarını ve migrasyon gelişimini öngören risk faktörlerini belirlemeyi amaçladık. Gereç ve Yöntemler: Kliniğimizde Aralık 2013 ile Nisan 2020 tarihleri arasında böbrek taşı için RIRC yapılan ve işlem sonrasında DJS yerleştirilmiş olan 1258 hastanın verileri geriye dönük olarak tarandı. DJS migrasyonu ile ilişkili bağımsız risk faktörlerini öngörmek için ikili lojistik regresyon analizi kullanıldı. Bulgular: 1258 hastadan 71’inde (%5,6) DJS migrasyonu gözlendi. Grup 1’de renal pelvis yerleşimli taşlar kaliks taşlarına oranla istatistiksel olarak daha fazlaydı (p=0,003). Hidronefroz grup 1’de %70,4 oranındayken; grup 2’de %56,2 oranında gözlendi (p=0,019). Üreteral erişim kılıfı kullanım oranı grup 1 ve grup 2’de sırasıyla %74,6 ve %57,5 idi (p=0,004). Grup 1’de modifiye Clavien-Dindo skoru 2,2±1,3 iken; grup 2’de 0,2±0,5 idi (p<0,001). Tek değişkenli ve çok değişkenli lojistik regresyon analizine göre renal pelvis yerleşimli taş olması (Tahmini rölatif risk (TRR)=2,080, %95 Güven Aralığı (GA): 1,277-3,388, p=0,003), toplayıcı sistemde derece 3-4 hidronefroz bulunması (TRR=3,732, %95GA: 1,783-7,809, p<0,001) ve üreteral erişim kılıfı kullanılması (TRR=2,387, %95GA: 1,368-4,162, p=0,002) DJS migrasyonunu öngören bağımsız risk faktörleridir. Sonuç: RIRC sonrasında gözlenen DJS migrasyonu nadir gözlenen bir komplikasyon olmasına rağmen özellikle proksimale doğru olan migrasyon sonrasında genel anestezi gerektiren ek bir işleme yol açması nedeniyle önemli bir komplikasyondur. Yüksek derecede hidronefrozu olan, renal pelviste taşı bulunan ve üreteral erişim kılıfı kullanılan hastalarda ameliyat sonrası dönemde DJS migrasyonu olabileceği unutulmamalıdır.

30 June 2022 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
FYFatih Yanaral
Fatih Yanaral
UCUfuk Caglar
Ufuk Caglar
FSFurkan Sendogan
Furkan Sendogan
MBMurat Bi̇nbay
Murat Bi̇nbay
Nowadays, active surveillance has gained popularity as an acceptable management alternative to definitive treatment for men with low-risk prostate cancer. Active surveillance aims to delay or prevent unnecessary interventions – thereby reducing the morbidity associated with overtreatment. Despite widespread acceptance from current guidelines, active surveillance does not eliminate the concern that the advanced disease and repeat biopsy anxiety for both the clinician and the patient. This situation leads to the search for a method that is non-invasive and can give an idea to the clinician about the status of the disease in the active surveillance protocol. Recent technological advancements and the introduction of modern anatomical and functional sequences have led to a growing role for multiparametric magnetic resonance imaging (mpMRI) in the detection, risk assessment, and monitoring of prostate cancer. The main advantages of MRI are its superior anatomic and contrast resolution, lack of ionizing radiation, and multi-planar capabilities. In addition, standardization of reporting findings such as PI-RADS in mpMRI in prostate cancer provides an advantage by increasing inter-reader reliability among radiologists. This study aims to evaluate and summarize the role of magnetic resonance imaging in the active surveillance of prostate cancer. Keywords: active surveilliance, prostate cancer, multiparametric magnetic resonance imaging

15 November 2019 in European Urology Supplements
Verified
Journal Article
Closed access
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
BCB. Can
B. Can
HKH.O. Kazan
H.O. Kazan
ÖEÖzgür Efiloğlu
Özgür Efiloğlu
FSFurkan Sendogan
Furkan Sendogan
AYAbdullah Yıldırım
Abdullah Yıldırım

25 August 2025 in Medicina
Verified
Journal Article
Open access
PDF file
UCUtku Can
Utku Can
BEBilal Eryildirim
Bilal Eryildirim
ACAlper COŞKUN
Alper COŞKUN
CCCengiz CANAKCI
Cengiz CANAKCI
FSFurkan Sendogan
Furkan Sendogan
KSKemal Sarıca
Kemal Sarıca
Background and Objectives: Ureteral kinking may hinder endoscopic access and reduce the success of ureteroscopic lithotripsy (URSL). This study evaluated whether kinking can be predicted preoperatively using non-contrast computed tomography (CT) by introducing a novel metric—Maximum Horizontal Ureteral Displacement (HUDmax)—and assessed its predictive value for procedural success. Materials and Methods: Data from 1261 patients who underwent URSL for a single ureteral stone were retrospectively analyzed. Patients were categorized into two groups based on whether the stone could be reached using a semirigid ureteroscope. Propensity score matching (1:2) was performed based on stone size and location, resulting in two matched cohorts: Group 1—Semirigid Inaccessible (SRI, n = 72), and Group 2—Semirigid Accessible (SRA, n = 144). Stone characteristics, ureteral wall thickness (UWT), and HUDmax were evaluated. Correlations between HUDmax and surgical parameters were analyzed, and the predictive value of HUDmax was assessed using receiver operating characteristic (ROC) analysis. Results: The SRI group showed significantly higher HUDmax values (median 2.36 mm vs. 1.2 mm, p < 0.0001). Semirigid access failure necessitated conversion to flexible ureteroscopy in all SRI cases, compared to 15% in the SRA group (p < 0.0001). Stone-free rates were significantly lower in the SRI group (45% vs. 82%, p < 0.0001), and the use of a double-J stent or nephrostomy placement was more frequent. Operative times were also longer in the SRI group (55 vs. 42 min, p < 0.0001). HUDmax correlated positively with operative time (r = 0.258, p = 0.005) but not with stone size, density, UWT, or hydronephrosis. ROC analysis showed HUDmax strongly predicted semirigid access failure (AUC: 0.805; cutoff: 1.58 mm), and moderately predicted stone-free status (AUC: 0.697; cutoff: 1.68 mm). Conclusions: Severe ureteral kinking constitutes a significant anatomical obstacle to the success of semirigid URSL. This study is the first to demonstrate that clinically relevant kinking can be predicted preoperatively using a non-contrast imaging modality, via the novel HUDmax parameter.